Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on October 2, 2006

Hypertension. 2006
Published online before print October 2, 2006, doi: 10.1161/01.HYP.0000245678.56354.21
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/6/1124    most recent
01.HYP.0000245678.56354.21v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirakawa, H.
Right arrow Articles by Hayashida, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirakawa, H.
Right arrow Articles by Hayashida, Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Other hypertension

Submitted on June 8, 2006
Revised on July 1, 2006

Autonomic Cardiovascular Responses to Heme Oxygenase Inhibition in Conscious Rats

Haruhisa Hirakawa and Yoshiaki Hayashida*

From the Department of Physiology (H.H.), National Defense Medical College, Saitama, Japan; and the Department of Health Science (Y.H.), International Buddhist University, Osaka, Japan.

* To whom correspondence should be addressed. E-mail: hayasida{at}mail.shitennoji.ac.jp.

Abstract--Carbon monoxide (CO) is produced in the course of heme degradation from biliverdin by heme oxygenase (HO) in various tissues, including the central nervous system. Recent studies suggest the inhibition of HO activity increases arterial pressure mediated by the autonomic nervous system. The present study was designed to investigate the autonomic regulation of cardiovascular responses to inhibition of endogenous CO production by the HO inhibitor Zinc deuteroporphyrin 2, 4-bis glycol (ZnDPBG) by using direct sympathetic nerve recordings in conscious, chronically instrumented rats. ZnDPBG induced increases in mean arterial pressure (MAP) (P<0.05) and renal sympathetic nerve activity (RSNA) (P<0.05) but no significant change in heart rate (P>0.05) in intact rats. In atropine-treated rats, ZnDPBG also induced increases in MAP (P<0.05) and RSNA (P<0.05) but no change in heart rate (P>0.05). In sinoaortic denervated rats, ZnDPBG induced increases in MAP (P<0.05), heart rate (P<0.05), and RSNA (P<0.05). ZnDPBG shifted the baroreflex curve for RSNA upward and to the right, which was characterized by increases in the maximum and minimum response and midpoint pressure without altering the maximum gain. These results indicate that inhibition of HO activity within the central nervous system causes sympathoexcitation, resulting in an increase in arterial pressure. We conclude that the CO/HO system plays an important role in cardiovascular regulation by modulating sympathetic tone.


Key words: carbon monoxide • heme oxygenase • autonomic nervous system • baroreflex • arterial pressure • heart rate • renal sympathetic nerve activity